Woodmont Investment Counsel LLC Has $316,000 Holdings in Colgate-Palmolive Company $CL

Woodmont Investment Counsel LLC lowered its holdings in Colgate-Palmolive Company (NYSE:CL) by 6.0% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,478 shares of the company’s stock after selling 222 shares during the quarter. Woodmont Investment Counsel LLC’s holdings in Colgate-Palmolive were worth $316,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the business. Personal CFO Solutions LLC bought a new position in Colgate-Palmolive in the first quarter valued at approximately $285,000. Vision Capital Management Inc. bought a new position in Colgate-Palmolive during the 1st quarter worth about $322,000. Autumn Glory Partners LLC lifted its stake in Colgate-Palmolive by 67.4% in the 1st quarter. Autumn Glory Partners LLC now owns 8,905 shares of the company’s stock valued at $851,000 after acquiring an additional 3,586 shares in the last quarter. Financial Gravity Asset Management Inc. acquired a new stake in Colgate-Palmolive in the 1st quarter valued at $2,166,000. Finally, Penserra Capital Management LLC boosted its position in Colgate-Palmolive by 398.6% during the first quarter. Penserra Capital Management LLC now owns 10,651 shares of the company’s stock valued at $997,000 after purchasing an additional 8,515 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Down 0.8%

Shares of CL stock opened at $77.39 on Tuesday. Colgate-Palmolive Company has a 12-month low of $77.32 and a 12-month high of $102.61. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The business has a 50-day moving average price of $83.11 and a two-hundred day moving average price of $88.21. The firm has a market cap of $62.55 billion, a P/E ratio of 21.74, a price-to-earnings-growth ratio of 4.06 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.03. The firm had revenue of $5.11 billion during the quarter, compared to the consensus estimate of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The business’s revenue was up 1.0% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.91 earnings per share. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a dividend yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio is currently 58.43%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on CL. JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating on the stock in a research report on Monday, August 4th. Wells Fargo & Company lowered their price objective on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research report on Thursday, September 25th. Weiss Ratings reiterated a “hold (c)” rating on shares of Colgate-Palmolive in a research report on Saturday, September 27th. Piper Sandler began coverage on Colgate-Palmolive in a research report on Friday. They set a “neutral” rating and a $84.00 price objective for the company. Finally, Citigroup reduced their price target on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating for the company in a report on Monday, August 4th. Seven analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Colgate-Palmolive currently has a consensus rating of “Hold” and an average target price of $94.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.